Federal contract award
75N91021F00016
DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N91019D00024 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $6.6M |
| Current contract value | $6.6M |
| Potential contract value / ceiling | $6.6M |
| Start date | Sep 16, 2021 |
| Current end date | Sep 15, 2026 |
| Potential end date | Sep 15, 2026 |
| Latest award activity | Jun 25, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 25, 2026 | P00003 | $109.3K | DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS |
| May 30, 2025 | P00002 | $0 | DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS |
| Nov 3, 2022 | P00001 | $0 | DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS |
| Sep 16, 2021 | 0 | $6.5M | DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.